Nucro-Technics Revenue and Competitors

Toronto, ON CAN

Location

N/A

Total Funding

Research

Industry

Estimated Revenue & Valuation

  • Nucro-Technics's estimated annual revenue is currently $10.5M per year.(i)
  • Nucro-Technics's estimated revenue per employee is $109,438

Employee Data

  • Nucro-Technics has 96 Employees.(i)
  • Nucro-Technics grew their employee count by 1% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.3M50%N/AN/A
#2
$49M43910%N/AN/A
#3
$0.7M11N/AN/AN/A
#4
$3.4M489%N/AN/A
#5
$12M13310%N/AN/A
#6
$24.6M2093%N/AN/A
#7
$27.6M2311%N/AN/A
#8
$26M2487%N/AN/A
#9
$6.7M65-4%N/AN/A
#10
$23.8M178-9%N/AN/A
Add Company

Since 1970, NUCRO-TECHNICS, a Pharmaceutical Contract Support Organization has been a partner to pharmaceutical and biopharmaceutical companies located all over the world. We’re located in a state-of-the-art 58,000 square foot facility that is a short drive from downtown Toronto and currently comprised of a staff of 135 scientific support personnel. Nucro-Technics is inspected by, and is in compliance with, the U.S. Food and Drug Administration (FDA), Health Canada, and is also certified to the ISO 9001:2000 standard. \r\n\r\nOur vision is to make our clients happy by providing excellent quality and service in all that we do.\r\n\r\nNUCRO-TECHNICS’ capabilities clearly distinguish us as a full service Pharmaceutical Contract Support Organization - with qualifications and experience significantly different from those organizations that provide only testing services. Almost since our inception, our scientists have been called upon to perform contract Research & Development work in the area of pharmaceutical and biopharmaceutical innovations. We have provided this support to a wide array of clients, large and small, as well as to trade associations, government agencies, and consultants. To date, NUCRO-TECHNICS has completed projects for 9 out of the 10 biggest pharmaceutical companies in the world.\r\n\r\nAlong with state-of-the-art facilities and equipment, renowned expertise, and broad scientific capabilities, we provide quality services and scientific excellence to all our clients. The breadth and depth of our expertise, and the strength of our dedication to client support can help you find and test workable answers to your unique challenges.

keywords:N/A

N/A

Total Funding

96

Number of Employees

$10.5M

Revenue (est)

1%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Nucro-Technics's People

NameTitleEmail/Phone
1
Report Writer / QC ReviewerReveal Email/Phone
2
Group LeadReveal Email/Phone
3
Genetic Toxicology AnalystReveal Email/Phone
4
Animal Facility SupervisorReveal Email/Phone
5
Director Compliance and Information ServicesReveal Email/Phone
6
Quality Assurance AssociateReveal Email/Phone
7
QC Specialist / ReviewerReveal Email/Phone
8
IT SpecialistReveal Email/Phone
9
MicrobiologistReveal Email/Phone
10
Director Toxicology LaboratoriesReveal Email/Phone

Nucro-Technics News

2022-04-20 - BetterLife To Present BETR-001 Preclinical Data at the Upcoming Canadian Association for Neuroscience Conference

The key PK data points from this mouse study conducted at Nucro-Technics (Scarborough, ON, Canada) include:.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$31.6M1014%N/A
#2
$33.8M1030%N/A
#3
$7.5M104-1%N/A
#4
$7.5M10710%N/A
#5
$31.8M1198%N/A